1. Search Result

Search Result

Targets Recommended: NEDD8-activating Enzyme

Results for "2267329-76-8" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-128862

    EGFR Cancer
    EGFR-IN-7 (compound 34) is a selective and potent EGFR kinase inhibitor extracted from patent WO2019015655A1, has IC50s of 7.92 nM and 0.218 nM for EGFR (WT) and EGFR (mutant C797S/T790M/L858R) respectively, and shows anti-tumor activity.